GPNMB and Parkinson disease: Most strikingly, the heightened expression of GPNMB has been associated with amyotrophic lateral sclerosis (ALS) [10,11], Parkinson’s disease [12,89,90] and Alzheimer’s Disease [91], all of which have pathogenic amyloids as major components of the disease progression.